HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE
|
|
- Dorothy Conley
- 5 years ago
- Views:
Transcription
1 HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE Author: Jenny Boyce, Lead Infection Prevention & Control Nurse Approved by and date: March 2016 Any other linked ICP Infection Prevention and Control Assurance Policies: Framework ICP Standard Precaution Policy Cleaning and Disinfection Procedure Decontamination Policy Outbreak Procedure Isolation Procedure Procedure number: ICPr006 Version control: Version 1:
2 Version Date Date of Next Reason for Change (eg. full No. Ratified/ Implementation Review rewrite, amendment to reflect Amended Date new legislation, updated flowchart, minor amendments, etc.) 1 01/03/16 30/09/2018 Changed from policy to procedure Page 2
3 TABLE OF CONTENTS 1. INTRODUCTION IDENTIFYING RISK OF INFECTION Communication Risk Assessment Risk assessment checklist Risk factors for contracting healthcare associated MRSA Risk Factors for Clostridium difficile-associated Diarrhoea Risk of Carbapenemase-producing Enterobacteriacea (CPE) REFERENCES AND BIBLIOGRAPHY APPENDIX 1 - Equality considerations... 8 APPENDIX 2 RISK ASSESSMENT TOOL FOR MENTAL HEALTH AND LEARNING DISABILITY SERVICES... 9 APPENDIX 3 RISK ASSESSMENT TOOL FOR Community Services Page 3
4 1. INTRODUCTION Healthcare associated infection (HCAI) risk assessments are undertaken to determine the risk of a patient contracting or spreading a healthcare associated infection and aids care planning and patient placement and transfer or discharge. A HCAI risk assessment should be undertaken on admission, transfer and if necessary on discharge of patients, using the risk assessment tool shown in Appendix 1, as part of the patient s assessment record on SystmOne or epex system. If completed prior to transfer or discharge to another hospital, or other care facility or where follow up by community staff is required, a copy of the assessment form should be included with the transfer/discharge summary paperwork which accompanies patient. 2. IDENTIFYING RISK OF INFECTION 2.1 Communication The presence of some infectious diseases such as MRSA does not usually prevent patient transfer to another ward or unit however; good communication before transfer will ensure that correct management measures are taken to reduce risks of spread. Good communication with the receiving facility within the Trust or external healthcare organisation will help determine e.g. whether the patient needs isolation facility or not. The Infection Prevention and Control Team (IP&CT) must be involved early in the management of HCAIs at the earliest opportunity. 2.2 Risk Assessment Once a risk assessment has been undertaken and infection hazards identified then an individual care plan must be put in place to minimise the risks. The patient and or the family must be informed of the status. This will include what level of personal protective equipment is needed, accommodation for patient, how to deal with any wounds, equipment management and if necessary transfer. For cases of MRSA or C.diff the integrated care pathway contained in the ICP006 and ICP007 policies must be used and any concerns must be discussed with the Infection Prevention and Control Team. A number of questions should be addressed when formulating the infection control care plan: Question What is the source or likely source of the infectious organism? How does the organism spread? Example Blood, faeces, urine or sputum. Direct or indirect contact, airborne or faecal oral.
5 Question Are there additional risk factors? What is the general mental and physical health of the patient? Are other patients, staff or visitors at risk? Availability of staff and facilities? What could be contaminated? Example Indwelling devices, wounds, antibiotics, incontinence, diarrhoea, impaired immunity, age, environmental conditions and Staff practice. Underlying diseases, dementia, immobility and poor personal hygiene. Sharing rooms, pregnant staff or visitors, older patients. Isolation facility, adequate staffing levels. Hands, face, clothing, linen, equipment and environment Risk assessment checklist The risk assessment checklist Appendix 2 & 3 contained in this procedure will assist you in deciding on the level of infection risk the patient faces or poses to others. The more Yes selected the higher the infection risk Risk factors for contracting healthcare associated MRSA Current or recent hospitalisation. MRSA remains a concern in hospitals, where it can attack those most vulnerable such as older adults and people with weakened immune systems and or recent surgery. Open wounds or burn, skin conditions or serious underlying health problems. Residing in a long-term care facility. MRSA is also prevalent in these facilities and carriers of MRSA have the ability to spread it, even if they're not showing signs of infection. Invasive devices. People who are catheterised, intravenous drips in situ or have feeding tubes or other invasive devices in situ are at higher risk. NB: If yes to questions marked * on assessment checklist, then patient should be considered high risk for MRSA acquisition and MRSA screening should be undertaken and if screening positive discuss further actions with IP&CT Risk Factors for Clostridium difficile-associated Diarrhoea Advanced age. Antibiotic therapy - The overuse of antibiotics, especially penicillin (ampicillin), clindamycin and cephalosporins. Placement of nasogastric tube. Prolonged hospital stay. Repeated enemas. Gastrointestinal tract surgery Sharing a room with a C.diff infected patient. Use of antacids Page 5
6 C. difficile-associated disease occurs when the normal intestinal flora is altered, allowing C. difficile to flourish in the intestinal tract and produce a toxin that causes a watery diarrhoea. The environment and equipment and hands can become contaminated and help to spread the infection Risk of Carbapenemase-producing Enterobacteriacea (CPE). Been in-patients in a hospital abroad, Serious medical conditions, Received multiple antibiotics, Complex surgery, Stayed in an intensive Care Unit, Insertion of foreign materials such as urinary catheters, ventilators or intravenous catheters. CPE is a group of bacteria that have become very resistant to antibiotics including those called carbapenems such as meropenem. Many of these bacteria usually live harmlessly in the gut of humans or animals and help digest food. However, if they get into the wrong place such as the bladder or blood stream they can cause infection such as urinary tract infections, wound infections and pneumonia. 3. REFERENCES AND BIBLIOGRAPHY Antibiotics: 'national threat' from steep rise in patients who are resistant to drugs. The Daily Telegraph, March Antibiotic resistance soars: Cases of gut bacteria not destroyed by drugs increase by 12,000% in seven years. Mail Online, March Department of Health (2007), Essential Steps to safe, clean care Inter-healthcare patient infection risk assessment form DH: London Fears that cases of antibiotic-resistant bacteria could get 'out of control'. The Independent, March The Health and Social Care Act 2008: Code of Practice on the prevention and control of infections and related guidance (2010) h_ pdf epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England (due for publication in the Journal of Hospital Infection January 2014) Page 6
7 Public Health England. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae (PDF 1.6Mb). March 2014 UK Standards for Microbiology Investigations: Laboratory Detection and Reporting of Bacteria with Carbapenem-Hydrolysing β-lactamases (carbapenemases) (2013) published at: Page 7
8 4. APPENDIX 1 - EQUALITY CONSIDERATIONS The Trust has a duty under the Equality Act and the Public Sector Equality Duty to assess the impact of Policy changes for different groups within the community. In particular, the Trust is required to assess the impact (both positive and negative) for a number of protected characteristics including: Age; Disability; Gender reassignment; Marriage and civil partnership; Race; Religion or belief; Sexual orientation; Pregnancy and maternity; and Other excluded groups and/or those with multiple and social deprivation (for example carers, transient communities, ex-offenders, asylum seekers, sex-workers and homeless people). The author has considered the impact on these groups of the adoption of this Policy and does not believe that there are any specific equality considerations that need to be taken into account. Page 8
9 APPENDIX 2 RISK ASSESSMENT TOOL FOR MENTAL HEALTH AND LEARNING DISABILITY SERVICES Admission Transfer Date... Patient/Service User details Name: Consultant: DOB: GP: Address Current Patient Location: MRSA Yes No N/K Is the patient known to be infected or colonised with MRSA? Has the patients been previously positive to MRSA? Has the patient had an MRSA screen undertaken? *Has the patient any wounds/skin lesions/pressure sores/leg ulcers? *Has the patient a history of frequent acute hospital admissions? Has the patient any indwelling devices i.e. urethral catheters, supra-pubic catheters and peg sites? If yes: Where...When... Result...(N/K = Not Known) NB: If yes to all questions * consider high risk and undertake MRSA screening as per procedure. If MRSA positive on admission or positive on screening please use integrated pathway in the procedure. Diarrhoea Yes No N/K Does the patient have diarrhoea? Is the diarrhoea thought to be of an infectious nature? Has a specimen been sent? Has an organism been identified? If yes: Where...When... Result... Has patient had treatment? If yes: What...and when completed... NB: Patients with diarrhoea caused by Clostridium difficile toxins or enteric pathogens such as E.coli or salmonella should be isolated in single room until 48 hours symptom free. There is also an integrated Clostridium difficile pathway available in the Procedure for the management of Clostridium difficile. Other communicable disorders Does the patient has or is suspected of having any of the following communicable disorders: Chicken pox or Smear positive TB Influenza Impetigo Scabies shingles Other please specify... Page 9
10 APPENDIX 3 RISK ASSESSMENT TOOL FOR COMMUNITY SERVICES The screenshot below is where the staff identify the level of risk of infection. All System One users must complete this form.
11
Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas
Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or
More informationDisclosure Status (B) B Can be disclosed to patients and the public
Policy: ICP12 MRSA Policy Version: ICP12/V7 Ratified by: Trust Management Team Date ratified: 11 March 2015 Title of Author: Infection Control Nurse Title of responsible Director Director of Nursing &
More informationTRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)
TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) Reference Number POL- IC/1082/14 Version 1.2.0 Status Final Author: Helen Forrest
More informationInfection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE)
Infection Prevention and Control Carbapenemase Producing Enterobacteriaceae (CPE) IPCT CPE Policy V4 May 2018 Policy Title: Executive Summary: Carbapenemase Producing Enterobacteriaceae (CPE) This policy
More informationPrevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015
Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in
More informationReducing the risk of healthcare associated infection
i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can
More informationCARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT
CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT Rick Catlin 04/04/18 CPE Carbapenemase producing enterobactericae Gut bacteria (enterobactericae) that have developed resistance to multiple
More informationInfection Prevention and Control Policy
Infection Prevention and Control Policy Version: 2 V Ratified By: Quality Sub Committee R Date Ratified: vember 2016 D Date Policy Comes Into Effect: vember 2016 D Author: Karen Taylor A Responsible Director:
More informationReducing the risk of healthcare associated infection
i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can
More informationSection G - Aseptic Technique. Version 5
Section G - Aseptic Technique Version 5 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or saved to another location, you must
More informationReducing HCAI- What the Commissioner needs to know.
Reducing HCAI- What the Commissioner needs to know. Sarah Mantle HCAI/AMR project lead NHS England #NHSEngAMR Do Tweet Introduction Healthcare Associated Infections (HCAI) can develop as a result of direct
More informationINFECTION PREVENTION AND CONTROL. Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy
INFECTION PREVENTION AND CONTROL Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy IPCT Multi-Resistant Gram Negative Bacilli Policy, V4, Dec 16 Page 1 Policy Title:
More informationCarbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO)
Carbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO) Information for patients and visitors This leaflet explains how we test for, treat and prevent the spread of
More informationDefinitions. Healthcare Acquired Infection (HCAI)
Infection Prevention and Control Assurance - Standard Operating Procedure 21 (IPC SOP 21) Alert Organisms Glycopeptide Resistant Enterococci (GRE) and Vancomycin Resistant Enterococci (VRE) Why we have
More informationDeveloped in response to: Best Practice Infection Prevention and Control
Transfer of patients within MEHT Clinical Guideline Developed in response to: Best Practice Infection Prevention and Control Version Number 1.0 Issuing Directorate Corporate Governance Approved by Clinical
More informationClostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions
Page 1 of 9 Standard Operating procedure (SOP) Objective To provide HCWs with details of the care required to prevent cross-infection in children s with Clostridium difficile Infection (CDI). This SOP
More informationSection J - Management of Patients with Multi Resistant Organisms:
Section J - Management of Patients with Multi Resistant Organisms: Carbapenemase-Producing Enterobacteriaceae (CPE) Vancomycin-Resistant Enterococci (VRE) Penicillin-Resistant Pneumococci (PRP) Extended
More informationNHS Professionals. POL6 Infection Control Policy
NHS Professionals POL6 Infection Control Policy Content Page Number Introduction 2 Scope of policy 2 Organisational structure and framework 3 Corporate Responsibilities 3 Partnership with NHS Trusts 4
More informationJob Title 22 February 2013
Surveillance of Infection Policy HH(1)/IC/613/13 Previous document(s) being replaced Location Policy Policy Name RHCH CP021 Surveillance Policy BNHH IC/289/09 Surveillance of Infection Protocol Document
More informationAlert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA
Infection Prevention and Control Assurance - Standard Operating Procedure 22 (IPC SOP 22) Alert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA Why we have a procedure? To ensure
More informationMETICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change
METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 10/2008 1 Guidance
More informationASSESSMENT ACTIVITY ANSWER PACK
ASSESSMENT ACTIVITY ANSWER PACK 1 Assessment Activity 1: What is Source Isolation?.. Briefly summarise why some patients require Source Isolation Care. Some patients infected or colonised with certain
More informationDirect cause of 5,000 deaths per year
HOSPITAL ACQUIRED (NOSOCOMIAL) INFECTION Policies MRSA Policy Meningitis Policy Blood and body fluid Exposure Policy Disinfection Policy Glove Policy Tuberculosis Policy Isolation Policy DEFINITION: ANY
More informationPROCEDURE FOR TAKING A WOUND SWAB
CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles
More informationyour hospitals, your health, our priority CATHETERISATION Urethral/ supra-pubic POLICY NAME: VERSION NUMBER : 1 PROFESSIONAL ADVISORY BOARD (PAB)
POLICY NAME: POLICY REFERENCE: CATHETERISATION Urethral/ supra-pubic TW12/016 VERSION NUMBER : 1 APPROVING COMMITTEE: PROFESSIONAL ADVISORY BOARD (PAB) DATE THIS VERSION APPROVED: RATIFYING COMMITTEE:
More informationIncludes GP flow chart & out of hours protocols. Page 1 of 11
Clostridium Difficile Policy. Precautions to be observed when caring for ECCH in-patients colonised or infected with Clostridium Difficile (C.difficile) Includes GP flow chart & out of hours protocols
More informationInfection Prevention Control Team
Title Document Type Document Number Version Number Approved by Infection Control Manual Section 3.1 Isolation Precautions and Infection Control Care Plan Policy 3 rd Edition Infection Control Committee
More informationMRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke
MRSA situations in Holland: What is behind the success? ICP, VieCuri Medical Centre Venlo, The Netherlands Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com INFECTION CONTROL HISTORY
More information01/09/2014. The very first requirement in a hospital is that it should do the sick no harm!!!!
Infection Prevention and Control A Foundation Course Update on recent Guidelines and Recommendations Ros Cashman Cork University Maternity Hospital, Cork 2014 The very first requirement in a hospital is
More informationInfection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy
Infection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy East Cheshire NHS Trust Infection Prevention and Control CPE V3 March 2016 1 Policy Title: Executive Summary: Carbapenemase
More informationDISCHARGE AND TRANSFER POLICY FOR MENTAL HEALTH AND LEARNING DISABILITIES
DISCHARGE AND TRANSFER POLICY FOR MENTAL HEALTH AND LEARNING DISABILITIES Policy Details NHFT document reference CLP056 Version Version 8 01.05.2015 Date Ratified 01.09.2015 Ratified by Trust Policy Board
More informationEarly detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0
Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing
More informationHealthcare associated infections across the health and social care community
Healthcare associated infections across the health and social care community Professor Brian Duerden CBE Inspector of Microbiology and Infection Control, Department of Health, London Infection is different..it
More informationSelf-Instructional Packet (SIP)
Self-Instructional Packet (SIP) Advanced Infection Prevention and Control Training Module 4 Transmission Based Precautions February 11, 2013 Page 1 Learning Objectives Module One Introduction to Infection
More informationConsumers Union/Safe Patient Project Page 1 of 7
Improving Hospital and Patient Safety: An overview of recently passed legislation and requirements towards improving the safety of California s hospital patients June 2009 Background Since 2006 several
More informationLightning Overview: Infection Control
Lightning Overview: Infection Control Gary Preston, PhD, CIC, FSHEA Terry Caton, CIC Carla Ward, CIC 2012 Healthcare Management Alternatives, Inc. Objectives At the end of this module you will know: How
More informationInfection Control Prevention Strategies. For Clinical Personnel
Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling
More informationASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY
ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 4 Update September 2012 Named Responsible Officer:- Approved by
More informationThe role of HIQA in Quality Improvement in Long-Term Care. Bríd McGoldrick Inspector Manager HIQA
The role of HIQA in Quality Improvement in Long-Term Care Bríd McGoldrick Inspector Manager HIQA Overview Regulations and Standards Annual Overview Report 2015 Governance Communication Regulation Directorate
More informationProcedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE)
SH CP 177 Procedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE) Infection Prevention and Control Policy: Appendix 21 Version 2 Summary: Defines the actions and management,
More informationBest Practice Guidelines BPG 5 Catheter Care
Best Practice Guidelines BPG 5 Catheter Care BGP 5 1 DOCUMENT STATUS: Reviewed DATE ISSUED: March 2014 DATE TO BE REVIEWED: 13.10.17 AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY V1 March 2014 New Guideline
More informationInfection Prevention and Control Assurance
Infection Prevention and Control Assurance Who Should Read This Policy Target Audience All Clinical Staff Version 1.0 November 2015 Infection Prevention and Control Assurance Policy Ref. Contents Page
More informationMRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of
MRSA INFORMATION LEAFLET for patients and relatives WHAT DOES MRSA STAND FOR? Meticillin Resistant Staphylococcus aureus. WHAT IS MRSA? Staphylococcus aureus is a germ that is commonly found both in hospital
More informationSECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)
SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication
More informationThe Management of Extended Spectrum Beta Lactamase-Producing Organisms Policy. Infection Prevention and Control
The Management of Extended Spectrum Beta Lactamase-Producing Organisms Policy Infection Prevention and Control This policy describes the key processes and protocols for patients colonised or infected with
More informationNational Standards for the prevention and control of healthcare-associated infections in acute healthcare services.
National Standards for the prevention and control of healthcare-associated infections in 2017 1 Safer Better Care Note on terms and abbreviations used in these standards A full range of terms and abbreviations
More informationChecklists for Preventing and Controlling
Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,
More informationPreventing Further Spread of CPE
Provisional Guidance relating to CPE for General Practice. May 26 2017. Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team. What is CPE (Carbapenemase Producing
More informationPreventing Cross-infection Patricia Folan and Lesley Baillie
CHAPTER 3 Preventing Cross-infection Patricia Folan and Lesley Baillie Preventing cross-infection is an essential activity for all nurses in their everyday practice. Nurses have an ethical and legal duty
More informationObjectives. Industry Landscape. Infection Prevention and Control Changes, Updates and Quality Results!
Infection Prevention and Control Changes, Updates and Quality Results! Sue LaGrange, RN, BSN, NHA, CDONA, FACDONA, CIMT Director of Education Pathway Health 1 Objectives 1.Describe the recent industry
More informationGlycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy
Glycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Animals on Hospital Premises Policy Version No. 6.0 Effective From: 16 March 2018 Expiry Date: 16 March 2021 Date Ratified: 06 March 2018 Ratified
More informationStandard Precautions for Infection Control
Standard Precautions for Infection Control Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne Golding-Ellis, Head of Patient Safety
More informationAnnual Infection Prevention and Control Report Produced by Colette Thomas Lead Nurse Infection Prevention and Control Page 1
Infection Prevention And Control Annual Report 2014-2015 Presented by: Written and Compiled by: Contributors: Executive Lead: Director of Infection Prevention and Control Lead Nurse, Infection Prevention
More informationINFECTION CONTROL SURVEILLANCE POLICY
INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection
More informationPrairie North Regional Health Authority: Hospital-acquired infections
Prairie North Regional Health Authority: Hospital-acquired infections Main points... 308 Introduction... 309 Background the risk of hospital-acquired infections... 309 Audit objective, scope, criteria,
More informationProtocol for the Prevention and Management of Clostridium difficile.
Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection
More informationSection J - Management of Patients with Multi Resistant Organisms:
Section J - Management of Patients with Multi Resistant Organisms: Carbapenemase-Producing Enterobacteriaceae (CPE) Vancomycin-Resistant Enterococci (VRE) Penicillin-Resistant Pneumococci (PRP) Extended
More informationDeveloped in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8
GRE (Glycopeptide Resistant Enterococci) Clinical Guideline Register No: 08028 Status: Public Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8 Consulted
More informationFive Top Tips to Prevent Infections in Long-term Care Settings
Five Top Tips to Prevent Infections in Long-term Care Settings Tip No. 1 Vigilance Open Your Eyes Staff Education Reduce Risks Be Proactive Know the Signs and Symptoms of Infection Tip No. 2 Hand Hygiene
More informationINFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM
INFECTION CONTROL EDUCATION PROGRAM Isolation Precautions Isolating the disease not the patient The Purpose is To protect compromised patient from environment To prevent the spread of communicable diseases.
More informationNHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes)
Page Page 1 of 9 SOP Objective To ensure Healthcare Workers (HCWs) are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical
More informationTRANSMISSION-BASED PRECAUTIONS
TRANSMISSION-BASED PRECAUTIONS PRECAUTIONS Standard Precautions infection prevention practices used with all patients regardless of suspected or confirmed diagnosis. Based on the principle that all blood,
More informationThe Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy
The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction
More informationNOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION
NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION DR AHMAD SHALTUT OTHMAN JAB ANESTESIOLOGI & RAWATAN RAPI HOSP SULTANAH BAHIYAH ALOR SETAR, KEDAH Nosocomial infection Nosocomial or hospital
More informationManagement of Patients with Diarrhoea
Management of Patients with Diarrhoea Reference No: Version: 1 Ratified by: G_IPC_45 LCHS Trust Board Date Ratified: 12 th January 2016 Name of originator/author: Name of responsible committee/individual:
More informationThe Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors
The Clatterbridge Cancer Centre NHS Foundation Trust MRSA Infection Control A guide for patients and visitors Contents Information... 1 Symptoms... 1 Diagnosis... 2 Treatment... 2 Prevention of spread...
More informationHCAI Local implementation team action plan
HCAI Local implementation team action plan Item Type Report Authors New Governance HCAI Group Publisher New Governance HCAI Group Download date 16/09/2018 18:12:09 Link to Item http://hdl.handle.net/10147/110814
More informationNorthumbria Healthcare NHS Foundation Trust. Infection Control Information for Patients and Visitors. Issued by The Infection Control Team
Northumbria Healthcare NHS Foundation Trust Infection Control Information for Patients and Visitors Issued by The Infection Control Team Introduction The purpose of this leaflet is to help you understand
More informationThe most up to date version of this policy can be viewed at the following website:
Page Page 1 of 6 Policy Objective To ensure that HCWs are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical conditions
More informationOther (please specify): Note: This document has been assessed for any equality, diversity or human rights implications
Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Nicola Colborne, Infection Prevention and Control Nurse Specialist
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationLearning Resource Pack: Source Isolation Version 2 (Aug 2005)
0 Contents.. Page No. Introduction 2 Assessment Activities 3 Aim and Learning Outcomes 4 Topic Sequencing Diagram 5 Section 1: What is Source Isolation? 6 Assessment Activity 1 8 Section 2: Principles
More informationInfection Prevention and Control
Infection Prevention and Control Infection Prevention and Control Program IPAC program consists of three healthcare professionals IPAC department is located on the 9 th floor and is available Monday to
More informationGeneral Practice Template. Guidelines for the Management of cases & outbreaks of Norovirus
General Practice Template Guidelines for the Management of cases & outbreaks of Norovirus Title: Procedural Document Type: Reference: Version: Ratified by: Date ratified: Freedom of Information: Name of
More informationAssessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE)
Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE) CPE Expert Group National Guidance Document, Version 1.0 Scope of this Guidance This guidance
More informationPolicy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)
Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance
More informationEnterobacteriaceae. Preventing the Spread of Carbapenemresistant. in LTCFs. Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion
Preventing the Spread of Carbapenemresistant Enterobacteriaceae in LTCFs Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion March 29, 2016 Preventing the Spread of Carbapenemresistant
More informationWhat you can do to help stop the spread of MRSA and other infections
MRSA wash it away As a patient it is important that you get better quickly and stay well. This leaflet gives you information about MRSA and other health care associated infections, so that you know what
More informationAntibiotic Use and Resistance in Nursing Homes
Antibiotic Use and Resistance in Nursing Homes GHINWA DUMYATI, MD PROFESSOR OF MEDICINE CENTER FOR COMMUNITY HEALTH UNIVERSITY OF ROCHESTER MEDICAL CENTER FEBRUARY 8, 2017 Nicolle LE, et al. Antimicrobial
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support The Open and Honest Care: Driving Improvement organisations to become more transparent
More informationInfection Control Prevention Strategies. For Clinical Personnel
Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling
More informationFF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION
IFF IFF DIFF. DIFF C. DIFF FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION Information for patients, their families and carers. What does it mean if someone has Clostridium difficile, or C. diff? These
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationClostridium difficile policy
Clostridium difficile policy Document level: Trustwide (TW) Code: IC5 Issue number: 4 Lead executive Director of Infection, Prevention and Control Author and contact number Infection Prevention and Control
More informationInfection Prevention and Control Annual Report
Infection Prevention and Control Annual Report 2015-16 Infection Prevention and Control Annual Report 2015-16 CONTENTS EXECUTIVE SUMMARY... 1 1. INTRODUCTION... 3 2. INFECTION PREVENTION AND CONTROL ARRANGEMENTS...
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support The Open and Honest Care: Driving Improvement organisations to become more transparent
More informationHereford Hospitals NHS Trust
Hereford Hospitals NHS Trust Universal Meticillin Resistant Staphylococcus Aureus (MRSA) Screening Protocol IC.08 IF THIS DOCUMENT HAS BEEN PRINTED, IT SHOULD NOT BE ASSUMED TO BE THE LATEST VERSION. Document
More informationInfection Prevention and Control for Phlebotomy
Page 1 of 10 POLICY STATEMENT: It is Sunnybrook s Policy to prevent the spread of infection within the health care institution from patient to patient, patient to staff, staff to patient by: a) providing
More informationWRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT
WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE
More informationAnimals and Pets in Healthcare Facilities Policy
Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,
More informationMRSA. Information for patients and carers. Delivering the best in care. UHB is a no smoking Trust
MRSA Information for patients and carers Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationClostridium difficile Infection (CDI) Trigger Tool
Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland March 2014 Version 3.0 A CDI trigger is the number of new CDI
More informationHealthcare-Associated Infections
Healthcare-Associated Infections A healthcare crisis requiring European leadership Healthcare-associated infections (HAIs - also referred to as nosocomial infections) are defined as an infection occurring
More informationReport of the unannounced inspection at Wexford General Hospital.
Report of the unannounced inspection of the prevention and control of healthcare associated infection at X Hospital Report of the unannounced inspection at Wexford General Hospital. Monitoring programme
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationTHE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION
THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION Compliance 1) Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider how susceptible
More informationInfection Prevention and Control Policy
Infection Prevention and Control Policy March 2012 Ref: PCD053 (v5) Status: Infection Prevention and Control Policy Policy Reference Number IC017 Status Version 5 Implementation Date September 2007 Current/Last
More informationRecommendations: Board members are requested to note the content of the report and priority areas for the coming year.
Trust Board Date: 24/05/2017 Purpose of the Report: Item: Annual Report Infection Prevention & Control. Enclosure: The Trust Board are provided with the Annual Report of Infection Prevention & Control
More information